News

Recent progress in the diagnosis and treatment of Primary Central Nervous System Lymphoma (PCNSL) has offered new hope for patients. A recent review from Stanford University highlights the importance of early diagnosis and the latest treatment options, including chemotherapy and targeted therapies.

A 34-year-old male patient shares his inspiring journey of battling acute myeloid leukemia (AML), undergoing multiple rounds of chemotherapy and a stem cell transplant, and celebrating three years of recovery and renewed hope.

A retrospective study evaluates the incidence and implications of oligoclonal protein bands (APB) in relapsed/refractory multiple myeloma (MM) patients treated with LCAR-B38M CAR-T therapy, highlighting their correlation with improved outcomes.

A young leukemia patient’s five-year battle against AML-M2, culminating in a successful haploidentical stem cell transplant at Lu Daopei Hospital, paves the way for his new life as a university student.

A large multi-center study in China reveals positive outcomes for patients with hematologic malignancies undergoing mismatched unrelated donor (MMUD) stem cell transplants with ATG for GVHD prevention

A 9-month-old child, diagnosed with high-risk Acute B Lymphoblastic Leukemia (B-ALL), undergoes a successful bone marrow transplant. Two years later, the child is thriving and ready for kindergarten.

A recent review in The Lancet Haematology highlights innovative advancements in CAR-T cell therapy, focusing on optimizing production speed, improving treatment efficacy, and expanding accessibility for patients with blood and solid tumors.

A recent study in the Journal of Clinical Oncology reports positive outcomes for CD19 CAR-T therapy brexucabtagene autoleucel (brexu-cel) in treating relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL), offering hope for high remission rates and improved survival in real-world settings.

Thalassemia is more than one disease. This guide explores both alpha and beta thalassemia, their causes, symptoms, and the latest treatment options available at BIOOCUS International Medical Center.

After a high-risk diagnosis of acute B-lymphoblastic leukemia and an initial transplant failure, a patient’s path to recovery seemed bleak. However, through the expertise of Lu Daopei’s medical team and a second transplant from a non-relative donor, hope and health have returned.

Jennifer Ficko, diagnosed with stage IV melanoma at 48, defied all expectations. Through groundbreaking treatments like TIL therapy and the unwavering support of her family, she has remained cancer-free for over seven years, celebrating a miraculous 14-year survival.

In 2016, an 11-year-old girl, Wenwen (alias), was diagnosed with acute T-cell lymphoblastic leukemia. Facing life-threatening challenges, she and her family turned to Lu Daopei Hospital for treatment. Today, after a successful transplant and years of recovery, she is thriving and preparing for her college entrance exams.